M4Q(R2)
Common Technical Document on Quality: Revision of M4Q(R1)
Current edition
Draft (Step 2b, 14 May 2025)
Current edition
Draft (Step 2b, 14 May 2025)
About this standard
A draft revision of the quality part of the dossier layout. It would apply to all chemical and biological drug substances and products that need a marketing authorization, and would build the quality section around the overall control strategy.
Draft only. ICH lists it at Step 3 after the Step 2b draft of 14 May 2025. The current final version is M4Q(R1).
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
No market listing is published yet.
Related standards: FDA eCTD submission guidance, MDR 2017 Fourth Schedule, Appendix II and III, JP notification on electronic study data (2024), M4(R4), M4Q(R1), M4S(R2), M4E(R2), ACTD, CDSCO Guidance for Industry (Biologicals), COFEPRIS CTD guide v3.0, DS-G-003, DS-REQ-002. See all standards.